Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA

Cancer Genetics and Cytogenetics

Volumn 99, Issue 2, 1997, Pages 108-115

  Weijerman, Philip C ^a   Van Drunen, Ellen ^a   König, Josee J ^a   Teubel, Wilma ^a   Romijn, Johannes C ^a   Schröder, Fritz H ^a   Hagemeijer, Anne ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL IMMORTALIZATION; CHROMOSOME 20; CHROMOSOME 5; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030864292     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00207-0     Document Type: Article

References (53)

1. Lu-Yao GL, Greenberg ER Changes in prostate cancer incidence and treatment in USA. Lancet. 343:1994;251-254.
2. Schröder FH, Damhuis RAM, Kirkels WJ, De Koning HJ, Kranse R, Nijs HGT, Blijenberg BG European randomized study of screening for prostate cancer - the Rotterdam pilot studies. Int J Cancer. 65:1996;145-151.
3. Peehl DM (1992): Culture of human prostatic epithelial cells. In: Culture of Epithelial Cells. IA Freshney, ed. Wiley-Liss, New York, pp. 159-180.
4. Weijerman PC, König JJ, Wong ST, Niesters HGM, Peehl DM Lipofection-mediated immortalization of human prostate epithelial cells of normal and malignant origin using human papilloma virus type 18 DNA. Cancer Res. 54:1994;5579-5583.
5. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WE Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA. 87:1990;8751-8755.
6. Bergerheim US, Kunimi K, Collins VP, Ekman P Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chromosom Cancer. 3:1991;215-220.
7. Brothman AR, Peehl DM, Patel AM, MacDonald GR, McNeal JE, Ladaga LE, Schellhammer PF Cytogenetic evaluation of 20 primary prostatic tumors. Cancer Genet Cytogen. 55:1991;79-84.
8. Sandberg AA Chromosomal abnormalities and related events in prostate cancer. Hum Pathol. 23:1992;368-380.
9. Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res. 53:1993;3869-3873.
10. Baretton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, Löhrs U Interphase cytogenetic analysis of prostatic carcinoma by use of non-isotopic in situ hybridization. Cancer Res. 54:1994;4472-4480.
11. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, Eschenbach AC von, Chung LWK, Liang JC Trisomy 7. a potential cytogenetic marker for human prostate cancer progression Genes Chromosom Cancer. 9:1994;19-27.
12. Alcarez A, Takahshi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res. 54:1994;3998-4003.
13. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P Genetic changes in primary and recurrent prostate cancer by comparitive genomic hybridization. Cancer Res. 55:1995;342-347.
14. Alers JC, Krijtenburg PJ, Visser KJ, Bosman FT, van der Kwast TH, van Dekken H Interphase cytogenetics of prostatic carcinoma and precursor lesions. analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias Genes Chromosom Cancer. 12:1995;241-250.
15. Qian J, Bostwick DG, Takahshi S, Borell TJ, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res. 55:1995;5408-5414.
16. König JJ, Teubel W, Romijn JC, Schröder FH, Hagemeijer A Gain and loss of chromosomes 1, 7, 8, 10, 18 and Y in 46 prostate cancers. Human Pathol. 27:1996;720-727.
17. Cher ML, Bova GS, Moore DH, Small EJ, Caroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization. Cancer Res. 56:1996;3091-3102.
18. Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovsky P, Nusskern DR, Damber J-E, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 274:1996;1371-1374.
19. König JJ, Kamst E, Hagemeijer A, Romijn JC, Horeszewicz J, Schröder FH Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol Res. 17:1989;79-86.
20. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, Nordenskjöld M, Pfragner R, Ponder BAJ Cytogenetic analysis by chromosome painting using flow-sorted chromosomes. Genes Chromosom Cancer. 4:1992;257-263.
21. Cooke HJ, Hindley J Cloning of human satellite III DNA. different components are on different chromosomes Nucl Acids Res. 6:1979;3177-3179.
22. Alexandrov IA, Mitkevich SP, Yurof YB The phylogeny of human chromosome specific alpha satellites. Chromosoma. 96:1988;443-453.
23. Donlon T, Wyman AR, Mulholland J, Barker D, Bruns G, Latt S, Botstein D Alpha satellite-like sequences at the centromeres of chromosome #8. Am J Hum Genet. 39:1986;A196.
24. Moyzis RK, Albright KL, Bartholdi MF, Cram LS, Deaven LL, Hildebrand CE, Joste NE, Longmire JL, Meyne J, Schwarzacher-Robinson T Human chromosome-specific repetitive DNA sequences. novel markers for genetic analysis Chromosoma. 95:1987;375-386.
25. Waye JS, Creeper LA, Willard HF Organization and evolution of alpha satellite DNA from human chromosome 11. Chromosoma. 95:1987;182-188.
26. Devilee P, Cremer T, Slagboom P, Bakker E, Scholl HP, Hager HD, Stevenson AF, Cornelisse CJ, Pearson PL Two subsets of human alphoid repetitive DNA show distinct preferential location in the pericentric regions of chromosomes 13, 18 and 21. Cytogenet Cell Genet. 41:1986;193-201.
27. Waye JS, Willard HF Chromosome specificity of satellite DNAs. short- and long-range organization of a diverged dimeric subset of human alpha satellite from chromosome 3 Chromosoma. 97:1989;475-480.
28. Weeda G, van Ham HC, Masurel R, Westerveld A, Odijk H, de Wit J, Bootsma D, van der Eb AJ, Hoeijmakers JH Molecular cloning and biological characterization of the human excision repair gene ERCC-3. Mol Cell Biol. 10:1990;2570-2581.
29. Kamb A, Gruis NA, Weaver-Feldhaus J, Lui Q, Harschman K, Tavtigian SV, Stockert E, Day RS, Johnson RE, Skolnick MH A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
30. Arnoldus EPJ, Wiegant J, Noordermeer IA, Wessels JA, Beverstock GC, Grosveld G, Van Der Ploeg M, Raap AK Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet. 54:1990;108.
31. McNicol PJ, Dodd JG High prevalence of human papillomavirus in prostate tissues. J Urol. 145:1991;850-852.
32. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M Presence of ras oncogene mutations and human papillomavirus DNA in prostate carcinomas. Cancer Res. 52:1992;5991-5996.
33. Rotola A, Monini D, Di Luca D, Savioli A, Simone R, Secchiero P, Reggiani A, Cassai E Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer. 52:1992;359-365.
34. Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson M, Robertson CN Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol. 148:1992;1822-1826.
35. Sarkar FH, Sakr WA, Li YW, Sreepathi P, Crissman JD Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR). Prostate. 22:1993;171-180.
36. Terris MK, McNeal JE, Freiha FS, Stamey TA, Peehl DM Human papillomavirus detection by PCR in benign and malignant prostate tissue is dependent on the primer set utilized. J Urol. 155:1996;343A.
37. Dodd JG, Paraskevas M, McNicol PJ Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol. 149:1993;400-403.
38. Cuzick J Human papillomavirus infection of the prostate. Cancer Surveys. 23:1995;91-95.
39. Kaighn ME, Roger RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Saffiotti U, Harris C Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV 40 early region genes. Cancer Res. 49:1989;3050-3056.
40. Cussenot O, Berthon P, Berger R, Mowszowics I, Faille A, Hojman F, Teillac P, Le Duc A, Calvo F Immortalization of human prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol. 143:1992;881-886.
41. Lee MS, Garvenko E, Yun JS, Weijerman PC, Peehl DM, Chen LS, Rhim JS Characterization of adult human prostate epithelial cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin defective SV40-genome. Int J Oncol. 4:1994;821-830.
42. Seagon S, Dürst M Genetic analysis of an in vitro model system for human papilloma virus type 16-associated tumorigenesis. Cancer Res. 54:1994;5593-5598.
43. Swisshelm K, Leonard M, Sager R Preferential chromosome loss in human papilloma virus DNA-immortalized mammary cells. Genes Chromosom Cancer. 5:1992;219-226.
44. Reznikoff CA, Savelieva E, Belair C, Waldman F, DeVries S, Newton MA Different combinations of genetic alterations in TCC pathogenesis. Urol Res. 23:1995;254.
45. DiPaolo JA, Popescu NC, Alvarez L, Woodworth CD Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. Crit Rev Oncogen. 4:1993;337-360.
46. Popescu NC, Zimonjic DB, Simpson S, Dipaolo JA Cumulative gene and chromosome alterations associated with in vitro neoplastic transformation of human cervical cells. Int J Oncol. 7:1995;279-285.
47. Dürst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE, Gissmann L Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1:1987;251-256.
48. Popescu NC, DiPaolo JA Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res. 50:1990;1316-1323.
49. Kovacs G, Tory K, Kovacs A Development of papillary tumours is associated with loss of Y-chromosome-specific DNA sequences. J Pathol. 173:1994;39-44.
50. Brown JA, Takahashi S, Alcaraz A, Borell TJ, Anderl KL, Qian J, Persons DL, Bostwick DG, Lieber MM, Jenkins RB. Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1 J Urol. 156:1996;31-35.
51. Limon J, Lundgren R, Elfving P, Heim S, Kristoffersson U, Mandahl N, Mitelman F Double minutes in two primary adenocarcinomas of the prostate. Cancer Genet Cytogenet. 39:1989;191-194.
52. Carroll SM, DeRose ML, Gaudray P, Moore CM, Needham-Vandevanter DR, Von Hoff DD, Wahl GM Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol Cell Biol. 8:1988;1525-1533.
53. Wolman SR, Henderson AS Chromosome aberrations as markers of oncogene amplification. Hum Pathol. 20:1989;308-315.